Receptor |
Coupling to effector system |
Body distribution |
Physiological function |
A1 |
G Protein-coupled: Gi
Adenylatecyclase: ↓cAMP
Kinase pathways: PKC, MAPK, PI3K
Ion channels: ↑K+, ↓Ca2+ |
Broad distribution:
high in nerves, heart,
kidney and adipose tissue |
Decreased renal blood flow, inhibition of renin release, inhibition of lipolysis, increased systemic blood pressure, vasoconstriction, bronchoconstriction, inhibition of neurotransmitter release, inhibition of insulin and glucagon release, reduced heart rate, sleep, analgesia, cardiac preconditioning |
A2A |
G Protein-coupled: Gs
Adenylatecyclase: ↑cAMP |
Broad distribution:
very high in basal ganglia; high in nerves, blood
vessels, kidney and immune cells |
Wakefulness and locomotion, increased renal flow, immunosuppression, vasodilation and hypotension, coronary vasodilation, angiogenesis, cardioprotection, baroreflex control |
A2B |
G Protein-coupled: Gs, Gq/11
Adenylatecyclase: ↑cAMP
Phospholipase C: ↑↓IP3, ↑Ca2+ |
Broad distribution, but generally low abundance |
Vascular integrity, cardiac preconditioning,
pro-inflammation (acute injury) and anti-inflammation (some chronic disease states), fibrosis |
A3 |
G Protein-coupled: Gi
Adenylatecyclase: ↓cAMP
kinase pathways: MAPK, PI3K
Phospholipase D, RhoA and Wnt pathways |
Restricted distribution, varying in different species: high in mast cells |
Increased mast cell activation, airway contraction, inflammatory pain, white cell chemotaxis, chronic neuropathic pain relief, anticancer (melanoma) |
|
Table 1: Classification, distribution and physiological function of the adenosine receptors [34,35,57,96,97,114,120]. cAMP, cyclic adenosine
monophosphate; PKC, protein kinase C, MAPK, mitogen-activated protein kinase; PI3K, phosphoinositide 3 kinase; IP3, inositol triphosphate;
RhoA, Ras homolog gene family member A. |